HEADER MEMBRANE PROTEIN 12-DEC-19 6TP3
TITLE CRYSTAL STRUCTURE OF THE OREXIN-1 RECEPTOR IN COMPLEX WITH
TITLE 2 DARIDOREXANT
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: OREXIN RECEPTOR TYPE 1;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: OX1R,HYPOCRETIN RECEPTOR TYPE 1;
COMPND 5 ENGINEERED: YES;
COMPND 6 MUTATION: YES;
COMPND 7 OTHER_DETAILS: DARIDOREXANT BOUND IN THE ORTHOSTERIC SITE
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: HCRTR1;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS 7TM, GPCR, MEMBRANE PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR M.RAPPAS,A.ALI,K.A.BENNETT,J.D.BROWN,S.J.BUCKNELL,M.CONGREVE,
AUTHOR 2 R.M.COOKE,G.CSEKE,C.DE GRAAF,A.S.DORE,J.C.ERREY,A.JAZAYERI,
AUTHOR 3 F.H.MARSHALL,J.S.MASON,R.MOULD,J.C.PATEL,B.G.TEHAN,M.WEIR,
AUTHOR 4 J.A.CHRISTOPHER
REVDAT 6 13-NOV-24 6TP3 1 REMARK
REVDAT 5 24-JAN-24 6TP3 1 HETSYN
REVDAT 4 29-JUL-20 6TP3 1 COMPND REMARK HETNAM SITE
REVDAT 3 11-MAR-20 6TP3 1 JRNL
REVDAT 2 29-JAN-20 6TP3 1 JRNL
REVDAT 1 01-JAN-20 6TP3 0
JRNL AUTH M.RAPPAS,A.A.E.ALI,K.A.BENNETT,J.D.BROWN,S.J.BUCKNELL,
JRNL AUTH 2 M.CONGREVE,R.M.COOKE,G.CSEKE,C.DE GRAAF,A.S.DORE,J.C.ERREY,
JRNL AUTH 3 A.JAZAYERI,F.H.MARSHALL,J.S.MASON,R.MOULD,J.C.PATEL,
JRNL AUTH 4 B.G.TEHAN,M.WEIR,J.A.CHRISTOPHER
JRNL TITL COMPARISON OF OREXIN 1 AND OREXIN 2 LIGAND BINDING MODES
JRNL TITL 2 USING X-RAY CRYSTALLOGRAPHY AND COMPUTATIONAL ANALYSIS.
JRNL REF J.MED.CHEM. V. 63 1528 2020
JRNL REFN ISSN 0022-2623
JRNL PMID 31860301
JRNL DOI 10.1021/ACS.JMEDCHEM.9B01787
REMARK 2
REMARK 2 RESOLUTION. 3.04 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.04
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.86
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 58.6
REMARK 3 NUMBER OF REFLECTIONS : 13842
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.207
REMARK 3 R VALUE (WORKING SET) : 0.205
REMARK 3 FREE R VALUE : 0.230
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 700
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.04
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.32
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 7.25
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2149
REMARK 3 BIN FREE R VALUE : 0.2547
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 28
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4982
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 417
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 121.7
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -3.63550
REMARK 3 B22 (A**2) : 2.21300
REMARK 3 B33 (A**2) : 1.42250
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -0.05500
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.440
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.498
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.891
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 5594 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 7630 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1936 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 833 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 5594 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 731 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 6524 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.00
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.98
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: {A|33 - 377}
REMARK 3 ORIGIN FOR THE GROUP (A): -24.0054 24.9609 -25.1908
REMARK 3 T TENSOR
REMARK 3 T11: -0.0464 T22: -0.2733
REMARK 3 T33: -0.2933 T12: 0.1317
REMARK 3 T13: 0.0608 T23: 0.0833
REMARK 3 L TENSOR
REMARK 3 L11: 2.6402 L22: 5.7085
REMARK 3 L33: 3.1093 L12: -0.6422
REMARK 3 L13: 0.0452 L23: 1.3706
REMARK 3 S TENSOR
REMARK 3 S11: 0.1115 S12: -0.6704 S13: 0.1417
REMARK 3 S21: -0.6704 S22: -0.0072 S23: -0.2533
REMARK 3 S31: 0.1417 S32: -0.2533 S33: -0.1044
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: {B|27 - 378}
REMARK 3 ORIGIN FOR THE GROUP (A): -15.7496 47.5332 -1.0274
REMARK 3 T TENSOR
REMARK 3 T11: -0.3186 T22: -0.2655
REMARK 3 T33: 0.0533 T12: 0.1245
REMARK 3 T13: -0.0429 T23: 0.1034
REMARK 3 L TENSOR
REMARK 3 L11: 1.3064 L22: 4.7838
REMARK 3 L33: 3.5861 L12: 0.0151
REMARK 3 L13: -0.4614 L23: 2.1341
REMARK 3 S TENSOR
REMARK 3 S11: 0.1241 S12: 0.3058 S13: -0.3281
REMARK 3 S21: 0.3058 S22: 0.1043 S23: 0.4013
REMARK 3 S31: -0.3281 S32: 0.4013 S33: -0.2284
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6TP3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-DEC-19.
REMARK 100 THE DEPOSITION ID IS D_1292105824.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-JUN-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 3.0-6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I24
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.96858
REMARK 200 MONOCHROMATOR : SI (111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : STARANISO
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13842
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.040
REMARK 200 RESOLUTION RANGE LOW (A) : 25.860
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 58.6
REMARK 200 DATA REDUNDANCY : 5.800
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.04
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.32
REMARK 200 COMPLETENESS FOR SHELL (%) : 7.3
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 6TO7
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 69.82
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.08
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRISODIUM CITRATE 50MM SODIUM
REMARK 280 CHLORIDE 50MM LITHIUM SULPHATE 15-34% PEG400, PH 4.8, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 284K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 73.21150
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ALA A 25
REMARK 465 ALA A 26
REMARK 465 SER A 27
REMARK 465 GLU A 28
REMARK 465 ASP A 29
REMARK 465 GLU A 30
REMARK 465 PHE A 31
REMARK 465 SER A 251A
REMARK 465 ALA A 251B
REMARK 465 LEU A 251C
REMARK 465 VAL A 251D
REMARK 465 ARG A 251E
REMARK 465 ASN A 251F
REMARK 465 TRP A 251G
REMARK 465 LYS A 251H
REMARK 465 ARG A 251I
REMARK 465 PRO A 251J
REMARK 465 SER A 251K
REMARK 465 ASP A 251L
REMARK 465 GLN A 251M
REMARK 465 LEU A 251N
REMARK 465 GLY A 251O
REMARK 465 ASP A 251P
REMARK 465 LEU A 251Q
REMARK 465 GLU A 251R
REMARK 465 GLN A 251S
REMARK 465 GLY A 251T
REMARK 465 LEU A 251U
REMARK 465 GLY A 252A
REMARK 465 GLU A 252B
REMARK 465 PRO A 252C
REMARK 465 GLN A 252D
REMARK 465 PRO A 252E
REMARK 465 ARG A 252F
REMARK 465 ALA A 252G
REMARK 465 ARG A 252H
REMARK 465 ALA A 252I
REMARK 465 PHE A 252J
REMARK 465 LEU A 252K
REMARK 465 PRO A 378
REMARK 465 GLY A 379
REMARK 465 LEU A 380
REMARK 465 ALA A 381
REMARK 465 ALA A 382
REMARK 465 ALA A 383
REMARK 465 HIS A 384
REMARK 465 HIS A 385
REMARK 465 HIS A 386
REMARK 465 HIS A 387
REMARK 465 HIS A 388
REMARK 465 HIS A 389
REMARK 465 HIS A 390
REMARK 465 HIS A 391
REMARK 465 HIS A 392
REMARK 465 ALA B 25
REMARK 465 ALA B 26
REMARK 465 VAL B 188
REMARK 465 LEU B 189
REMARK 465 PRO B 190
REMARK 465 GLU B 191
REMARK 465 LEU B 192
REMARK 465 ALA B 193
REMARK 465 ALA B 194
REMARK 465 ARG B 195
REMARK 465 THR B 196
REMARK 465 ARG B 197
REMARK 465 ALA B 198
REMARK 465 GLY B 244
REMARK 465 ARG B 245
REMARK 465 SER B 251A
REMARK 465 ALA B 251B
REMARK 465 LEU B 251C
REMARK 465 VAL B 251D
REMARK 465 ARG B 251E
REMARK 465 ASN B 251F
REMARK 465 TRP B 251G
REMARK 465 LYS B 251H
REMARK 465 ARG B 251I
REMARK 465 PRO B 251J
REMARK 465 SER B 251K
REMARK 465 ASP B 251L
REMARK 465 GLN B 251M
REMARK 465 LEU B 251N
REMARK 465 GLY B 251O
REMARK 465 ASP B 251P
REMARK 465 LEU B 251Q
REMARK 465 GLU B 251R
REMARK 465 GLN B 251S
REMARK 465 GLY B 251T
REMARK 465 LEU B 251U
REMARK 465 GLY B 252A
REMARK 465 GLU B 252B
REMARK 465 PRO B 252C
REMARK 465 GLN B 252D
REMARK 465 PRO B 252E
REMARK 465 ARG B 252F
REMARK 465 ALA B 252G
REMARK 465 ARG B 252H
REMARK 465 ALA B 252I
REMARK 465 PHE B 252J
REMARK 465 LEU B 252K
REMARK 465 GLY B 379
REMARK 465 LEU B 380
REMARK 465 ALA B 381
REMARK 465 ALA B 382
REMARK 465 ALA B 383
REMARK 465 HIS B 384
REMARK 465 HIS B 385
REMARK 465 HIS B 386
REMARK 465 HIS B 387
REMARK 465 HIS B 388
REMARK 465 HIS B 389
REMARK 465 HIS B 390
REMARK 465 HIS B 391
REMARK 465 HIS B 392
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 NZ LYS A 43 O ASP A 107 2.16
REMARK 500 OH TYR B 224 O ALA B 308 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 CE1 TYR A 41 CD2 LEU B 40 2445 1.22
REMARK 500 CD1 TYR A 41 CD2 LEU B 40 2445 2.06
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 42 C - N - CD ANGL. DEV. = -18.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 TYR A 41 -75.31 -77.35
REMARK 500 TYR A 224 -65.73 -138.78
REMARK 500 TYR B 39 -65.39 -139.63
REMARK 500 LEU B 152 31.43 -99.70
REMARK 500 ILE B 247 49.55 -157.52
REMARK 500
REMARK 500 REMARK: NULL
REMARK 610
REMARK 610 MISSING HETEROATOM
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 610 I=INSERTION CODE):
REMARK 610 M RES C SSEQI
REMARK 610 SOG A 408
REMARK 610 SOG B 406
REMARK 610 SOG B 407
REMARK 610 SOG B 408
REMARK 610 SOG B 409
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6TOT RELATED DB: PDB
REMARK 900 RELATED ID: 6TOS RELATED DB: PDB
REMARK 900 RELATED ID: 6TOD RELATED DB: PDB
REMARK 900 RELATED ID: 6TO7 RELATED DB: PDB
DBREF 6TP3 A 28 380 UNP O43613 OX1R_HUMAN 28 380
DBREF 6TP3 B 28 380 UNP O43613 OX1R_HUMAN 28 380
SEQADV 6TP3 ALA A 25 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA A 26 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 SER A 27 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA A 46 UNP O43613 GLU 46 ENGINEERED MUTATION
SEQADV 6TP3 LEU A 85 UNP O43613 ILE 85 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 95 UNP O43613 VAL 95 ENGINEERED MUTATION
SEQADV 6TP3 LEU A 162 UNP O43613 ARG 162 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 194 UNP O43613 ASN 194 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 198 UNP O43613 LEU 198 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 211 UNP O43613 TYR 211 ENGINEERED MUTATION
SEQADV 6TP3 VAL A 304 UNP O43613 LEU 304 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 339 UNP O43613 CYS 339 ENGINEERED MUTATION
SEQADV 6TP3 TRP A 375 UNP O43613 CYS 375 ENGINEERED MUTATION
SEQADV 6TP3 TRP A 376 UNP O43613 CYS 376 ENGINEERED MUTATION
SEQADV 6TP3 ALA A 381 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA A 382 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA A 383 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 384 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 385 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 386 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 387 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 388 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 389 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 390 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 391 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS A 392 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA B 25 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA B 26 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 SER B 27 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA B 46 UNP O43613 GLU 46 ENGINEERED MUTATION
SEQADV 6TP3 LEU B 85 UNP O43613 ILE 85 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 95 UNP O43613 VAL 95 ENGINEERED MUTATION
SEQADV 6TP3 LEU B 162 UNP O43613 ARG 162 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 194 UNP O43613 ASN 194 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 198 UNP O43613 LEU 198 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 211 UNP O43613 TYR 211 ENGINEERED MUTATION
SEQADV 6TP3 VAL B 304 UNP O43613 LEU 304 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 339 UNP O43613 CYS 339 ENGINEERED MUTATION
SEQADV 6TP3 TRP B 375 UNP O43613 CYS 375 ENGINEERED MUTATION
SEQADV 6TP3 TRP B 376 UNP O43613 CYS 376 ENGINEERED MUTATION
SEQADV 6TP3 ALA B 381 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA B 382 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 ALA B 383 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 384 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 385 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 386 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 387 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 388 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 389 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 390 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 391 UNP O43613 EXPRESSION TAG
SEQADV 6TP3 HIS B 392 UNP O43613 EXPRESSION TAG
SEQRES 1 A 368 ALA ALA SER GLU ASP GLU PHE LEU ARG TYR LEU TRP ARG
SEQRES 2 A 368 ASP TYR LEU TYR PRO LYS GLN TYR ALA TRP VAL LEU ILE
SEQRES 3 A 368 ALA ALA TYR VAL ALA VAL PHE VAL VAL ALA LEU VAL GLY
SEQRES 4 A 368 ASN THR LEU VAL CYS LEU ALA VAL TRP ARG ASN HIS HIS
SEQRES 5 A 368 MET ARG THR VAL THR ASN TYR PHE LEU VAL ASN LEU SER
SEQRES 6 A 368 LEU ALA ASP VAL LEU ALA THR ALA ILE CYS LEU PRO ALA
SEQRES 7 A 368 SER LEU LEU VAL ASP ILE THR GLU SER TRP LEU PHE GLY
SEQRES 8 A 368 HIS ALA LEU CYS LYS VAL ILE PRO TYR LEU GLN ALA VAL
SEQRES 9 A 368 SER VAL SER VAL ALA VAL LEU THR LEU SER PHE ILE ALA
SEQRES 10 A 368 LEU ASP ARG TRP TYR ALA ILE CYS HIS PRO LEU LEU PHE
SEQRES 11 A 368 LYS SER THR ALA ARG ARG ALA LEU GLY SER ILE LEU GLY
SEQRES 12 A 368 ILE TRP ALA VAL SER LEU ALA ILE MET VAL PRO GLN ALA
SEQRES 13 A 368 ALA VAL MET GLU CYS SER SER VAL LEU PRO GLU LEU ALA
SEQRES 14 A 368 ALA ARG THR ARG ALA PHE SER VAL CYS ASP GLU ARG TRP
SEQRES 15 A 368 ALA ASP ASP LEU ALA PRO LYS ILE TYR HIS SER CYS PHE
SEQRES 16 A 368 PHE ILE VAL THR TYR LEU ALA PRO LEU GLY LEU MET ALA
SEQRES 17 A 368 MET ALA TYR PHE GLN ILE PHE ARG LYS LEU TRP GLY ARG
SEQRES 18 A 368 GLN ILE PRO GLY THR THR SER ALA LEU VAL ARG ASN TRP
SEQRES 19 A 368 LYS ARG PRO SER ASP GLN LEU GLY ASP LEU GLU GLN GLY
SEQRES 20 A 368 LEU SER GLY GLU PRO GLN PRO ARG ALA ARG ALA PHE LEU
SEQRES 21 A 368 ALA GLU VAL LYS GLN MET ARG ALA ARG ARG LYS THR ALA
SEQRES 22 A 368 LYS MET LEU MET VAL VAL VAL LEU VAL PHE ALA LEU CYS
SEQRES 23 A 368 TYR LEU PRO ILE SER VAL LEU ASN VAL LEU LYS ARG VAL
SEQRES 24 A 368 PHE GLY MET PHE ARG GLN ALA SER ASP ARG GLU ALA VAL
SEQRES 25 A 368 TYR ALA ALA PHE THR PHE SER HIS TRP LEU VAL TYR ALA
SEQRES 26 A 368 ASN SER ALA ALA ASN PRO ILE ILE TYR ASN PHE LEU SER
SEQRES 27 A 368 GLY LYS PHE ARG GLU GLN PHE LYS ALA ALA PHE SER TRP
SEQRES 28 A 368 TRP LEU PRO GLY LEU ALA ALA ALA HIS HIS HIS HIS HIS
SEQRES 29 A 368 HIS HIS HIS HIS
SEQRES 1 B 368 ALA ALA SER GLU ASP GLU PHE LEU ARG TYR LEU TRP ARG
SEQRES 2 B 368 ASP TYR LEU TYR PRO LYS GLN TYR ALA TRP VAL LEU ILE
SEQRES 3 B 368 ALA ALA TYR VAL ALA VAL PHE VAL VAL ALA LEU VAL GLY
SEQRES 4 B 368 ASN THR LEU VAL CYS LEU ALA VAL TRP ARG ASN HIS HIS
SEQRES 5 B 368 MET ARG THR VAL THR ASN TYR PHE LEU VAL ASN LEU SER
SEQRES 6 B 368 LEU ALA ASP VAL LEU ALA THR ALA ILE CYS LEU PRO ALA
SEQRES 7 B 368 SER LEU LEU VAL ASP ILE THR GLU SER TRP LEU PHE GLY
SEQRES 8 B 368 HIS ALA LEU CYS LYS VAL ILE PRO TYR LEU GLN ALA VAL
SEQRES 9 B 368 SER VAL SER VAL ALA VAL LEU THR LEU SER PHE ILE ALA
SEQRES 10 B 368 LEU ASP ARG TRP TYR ALA ILE CYS HIS PRO LEU LEU PHE
SEQRES 11 B 368 LYS SER THR ALA ARG ARG ALA LEU GLY SER ILE LEU GLY
SEQRES 12 B 368 ILE TRP ALA VAL SER LEU ALA ILE MET VAL PRO GLN ALA
SEQRES 13 B 368 ALA VAL MET GLU CYS SER SER VAL LEU PRO GLU LEU ALA
SEQRES 14 B 368 ALA ARG THR ARG ALA PHE SER VAL CYS ASP GLU ARG TRP
SEQRES 15 B 368 ALA ASP ASP LEU ALA PRO LYS ILE TYR HIS SER CYS PHE
SEQRES 16 B 368 PHE ILE VAL THR TYR LEU ALA PRO LEU GLY LEU MET ALA
SEQRES 17 B 368 MET ALA TYR PHE GLN ILE PHE ARG LYS LEU TRP GLY ARG
SEQRES 18 B 368 GLN ILE PRO GLY THR THR SER ALA LEU VAL ARG ASN TRP
SEQRES 19 B 368 LYS ARG PRO SER ASP GLN LEU GLY ASP LEU GLU GLN GLY
SEQRES 20 B 368 LEU SER GLY GLU PRO GLN PRO ARG ALA ARG ALA PHE LEU
SEQRES 21 B 368 ALA GLU VAL LYS GLN MET ARG ALA ARG ARG LYS THR ALA
SEQRES 22 B 368 LYS MET LEU MET VAL VAL VAL LEU VAL PHE ALA LEU CYS
SEQRES 23 B 368 TYR LEU PRO ILE SER VAL LEU ASN VAL LEU LYS ARG VAL
SEQRES 24 B 368 PHE GLY MET PHE ARG GLN ALA SER ASP ARG GLU ALA VAL
SEQRES 25 B 368 TYR ALA ALA PHE THR PHE SER HIS TRP LEU VAL TYR ALA
SEQRES 26 B 368 ASN SER ALA ALA ASN PRO ILE ILE TYR ASN PHE LEU SER
SEQRES 27 B 368 GLY LYS PHE ARG GLU GLN PHE LYS ALA ALA PHE SER TRP
SEQRES 28 B 368 TRP LEU PRO GLY LEU ALA ALA ALA HIS HIS HIS HIS HIS
SEQRES 29 B 368 HIS HIS HIS HIS
HET NS2 A 401 55
HET SO4 A 402 5
HET SO4 A 403 5
HET PGW A 404 51
HET SOG A 405 20
HET SOG A 406 20
HET SOG A 407 20
HET SOG A 408 14
HET SOG A 409 20
HET SOG A 410 20
HET SOG A 411 20
HET NS2 B 401 55
HET SO4 B 402 5
HET PGW B 403 51
HET SOG B 404 20
HET SOG B 405 20
HET SOG B 406 13
HET SOG B 407 5
HET SOG B 408 12
HET SOG B 409 12
HET SOG B 410 20
HETNAM NS2 [(2~{S})-2-(6-CHLORANYL-7-METHYL-1~{H}-BENZIMIDAZOL-2-
HETNAM 2 NS2 YL)-2-METHYL-PYRROLIDIN-1-YL]-[5-METHOXY-2-(1,2,3-
HETNAM 3 NS2 TRIAZOL-2-YL)PHENYL]METHANONE
HETNAM SO4 SULFATE ION
HETNAM PGW (1R)-2-{[(S)-{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)
HETNAM 2 PGW PHOSPHORYL]OXY}-1-[(HEXADECANOYLOXY)METHYL]ETHYL (9Z)-
HETNAM 3 PGW OCTADEC-9-ENOATE
HETNAM SOG OCTYL 1-THIO-BETA-D-GLUCOPYRANOSIDE
HETSYN PGW 1-PALMITOYL-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-(1-
HETSYN 2 PGW GLYCEROL)]; PHOSPHATIDYLGLYCEROL
HETSYN SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-
HETSYN 2 SOG TRIOL; 1-S-OCTYL-BETA-D-THIOGLUCOSIDE; OCTYL 1-THIO-
HETSYN 3 SOG BETA-D-GLUCOSIDE; OCTYL 1-THIO-D-GLUCOSIDE; OCTYL 1-
HETSYN 4 SOG THIO-GLUCOSIDE
FORMUL 3 NS2 2(C23 H23 CL N6 O2)
FORMUL 4 SO4 3(O4 S 2-)
FORMUL 6 PGW 2(C40 H77 O10 P)
FORMUL 7 SOG 14(C14 H28 O5 S)
HELIX 1 AA1 TYR A 45 ASN A 74 1 30
HELIX 2 AA2 HIS A 75 ARG A 78 5 4
HELIX 3 AA3 THR A 79 ILE A 98 1 20
HELIX 4 AA4 ILE A 98 GLU A 110 1 13
HELIX 5 AA5 PHE A 114 CYS A 149 1 36
HELIX 6 AA6 THR A 157 MET A 176 1 20
HELIX 7 AA7 MET A 176 VAL A 182 1 7
HELIX 8 AA8 LEU A 189 ARG A 195 5 7
HELIX 9 AA9 ASP A 209 TYR A 224 1 16
HELIX 10 AB1 TYR A 224 TRP A 243 1 20
HELIX 11 AB2 THR A 251 VAL A 323 1 41
HELIX 12 AB3 ASP A 332 SER A 362 1 31
HELIX 13 AB4 SER A 362 LEU A 377 1 16
HELIX 14 AB5 GLU B 28 TYR B 39 1 12
HELIX 15 AB6 TYR B 39 ASN B 74 1 36
HELIX 16 AB7 HIS B 75 ARG B 78 5 4
HELIX 17 AB8 THR B 79 ILE B 98 1 20
HELIX 18 AB9 ILE B 98 GLU B 110 1 13
HELIX 19 AC1 PHE B 114 CYS B 149 1 36
HELIX 20 AC2 THR B 157 MET B 176 1 20
HELIX 21 AC3 MET B 176 VAL B 182 1 7
HELIX 22 AC4 ASP B 209 TYR B 224 1 16
HELIX 23 AC5 TYR B 224 TRP B 243 1 20
HELIX 24 AC6 ALA B 253 VAL B 323 1 39
HELIX 25 AC7 ASP B 332 SER B 362 1 31
HELIX 26 AC8 SER B 362 TRP B 376 1 15
SHEET 1 AA1 2 MET A 183 SER A 187 0
SHEET 2 AA1 2 SER A 200 GLU A 204 -1 O ASP A 203 N GLU A 184
SHEET 1 AA2 2 MET B 183 SER B 186 0
SHEET 2 AA2 2 VAL B 201 GLU B 204 -1 O ASP B 203 N GLU B 184
SSBOND 1 CYS A 119 CYS A 202 1555 1555 2.06
SSBOND 2 CYS B 119 CYS B 202 1555 1555 2.04
CRYST1 61.223 146.423 73.600 90.00 109.55 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016334 0.000000 0.005800 0.00000
SCALE2 0.000000 0.006830 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014418 0.00000